Add to my selection

LECIGIMON (lévodopa/ carbidopa/ entacapone)

Medicine - Posted on Jan 09 2023

Active substance (DCI)

lévodopa
carbidopa
entacapone

history (2)

12/14/22

LECIGIMON (lévodopa / carbidopa / entacapone) - Maladie de Parkinson

Key points Approval of reimbursement for the treatment of advanced-stage Parkinson’s disease with motor fluctuations and hyp...

CAV :
54321

icône flèche
3/30/22

LECIGIMON (lévodopa/ carbidopa/ entacapone) - maladie de Parkinson à un stade avancé

Key points Unfavourable opinion for reimbursement in the treatment of advanced Parkinson's disease with severe motor fluctua...

CAV :
54321

icône flèche

Technical information

ATC code

N04BA03

Manufacturer

EG LABO - LABORATOIRES EUROGENERIC

Presentation

LECIGIMON 20 mg/5 mg/20 mg par ml, gel intestinal
Boite de 7 cassettes polyprolène de 47 ml (CIP : 34009 302 356 1 4)

All our publications

Central nervous system diseases

Neurodegenerative diseases